World AIDS Day 2025: Recap and Ongoing Commitments
A look back at this year's World AIDS Day events and the renewed global commitments to ending the HIV epidemic.
A look back at this year's World AIDS Day events and the renewed global commitments to ending the HIV epidemic.
Every December 1st, the world pauses to mark World AIDS Day — a global health observance that has been held since 1988, making it one of the longest-running international health awareness days. World AIDS Day 2025 carried the theme "Take the Rights Path: My Health, My Right!" — a call to action to uphold the human rights of people living with HIV and to remove the legal and social barriers that prevent people from accessing HIV prevention, testing, and treatment.
World AIDS Day 2025 saw thousands of events held across the globe, from candlelight vigils to scientific symposia, community health fairs, and advocacy rallies. The iconic UNAIDS red ribbon — the universal symbol of awareness and support for people living with HIV — was displayed on landmarks from the Eiffel Tower to the Empire State Building.
At the United Nations in New York, world leaders reaffirmed their commitment to the 2021 Political Declaration on HIV and AIDS, which set ambitious targets to end AIDS as a public health threat by 2030. The declaration calls for 95% of people with HIV to know their status, 95% of those diagnosed to be on treatment, and 95% of those on treatment to achieve viral suppression — the so-called "95-95-95" targets.
UNAIDS reported that as of 2024, approximately 39.9 million people worldwide are living with HIV. While global progress has been made — with 29.8 million people accessing antiretroviral therapy — significant gaps remain, particularly in sub-Saharan Africa, Eastern Europe, and Central Asia.
In the United States, the Ending the HIV Epidemic in the U.S. (EHE) initiative continued to show results in 2025. The initiative, launched in 2019, aims to reduce new HIV infections by 75% by 2025 and by 90% by 2030. Key strategies include expanding HIV testing, accelerating PrEP uptake, rapidly connecting people to treatment, and responding to HIV outbreaks.
The CDC's HIV Surveillance Report for 2024 showed that new HIV diagnoses in the U.S. have declined by approximately 12% over the past five years. However, disparities persist: Black and Hispanic/Latino communities continue to bear a disproportionate burden of new HIV diagnoses, accounting for approximately 42% and 29% of new diagnoses respectively, despite representing smaller proportions of the total U.S. population.
PrEP uptake has increased significantly, with approximately 360,000 people in the U.S. using PrEP in 2024. However, PrEP coverage remains unequal: Black and Hispanic individuals, who are at highest risk for HIV, have lower rates of PrEP use compared to white individuals. Addressing these disparities is a central focus of the EHE initiative.
The 2025 World AIDS Day theme highlighted the inextricable link between human rights and the HIV response. Criminalization of HIV transmission, sex work, and drug use continues to drive people away from HIV services in many countries. The Center for HIV Law and Policy reports that more than 60 countries have HIV-specific criminal laws, and many more have general criminal laws that have been applied to HIV transmission.
Stigma and discrimination remain major barriers to HIV testing and treatment. UNAIDS data shows that stigma is one of the most commonly reported barriers to HIV testing globally. People who fear discrimination may avoid testing, delay treatment, or disengage from care — with serious consequences for their health and for public health.
Advocates called on governments to repeal punitive laws, invest in community-led responses, and ensure that HIV services are accessible to all people, regardless of gender, sexual orientation, race, immigration status, or socioeconomic status.
World AIDS Day 2025 also celebrated significant scientific progress. The field of long-acting HIV treatment and prevention continued to advance, with several new long-acting injectable and implantable options in late-stage clinical trials. The ClinicalTrials.gov registry listed over 200 active HIV vaccine trials as of late 2025.
The International AIDS Vaccine Initiative (IAVI) and the HIV Vaccine Trials Network (HVTN) reported promising early results from mRNA-based HIV vaccine candidates, building on the success of mRNA technology in COVID-19 vaccines. While an effective HIV vaccine remains elusive, researchers expressed cautious optimism about the new approaches being tested.
In the realm of HIV cure research, the amfAR and International AIDS Society reported continued progress in understanding HIV reservoirs — the cells where HIV hides even during effective treatment. Several "kick and kill" and "block and lock" strategies are being investigated to eliminate or permanently silence these reservoirs.
World AIDS Day 2025 amplified the voices of people living with HIV and the communities most affected by the epidemic. Community-based organizations across the U.S. held events to honor those lost to AIDS, celebrate the resilience of survivors, and advocate for continued investment in the HIV response.
Organizations like TheBody.com, POZ Magazine, and Positively Aware published special World AIDS Day content featuring personal stories, expert interviews, and advocacy calls to action.
As we look toward 2030 — the target year for ending AIDS as a public health threat — the challenges are significant but not insurmountable. Achieving the 95-95-95 targets will require sustained political will, adequate funding, and a commitment to addressing the social determinants of health that drive HIV disparities.
The U.S. President's Emergency Plan for AIDS Relief (PEPFAR), now in its third decade, remains the largest commitment by any nation to address a single disease in history, having saved an estimated 25 million lives. Continued investment in PEPFAR and domestic HIV programs is essential to reaching the 2030 goals.
World AIDS Day reminds us that the fight against HIV is far from over — but with science, solidarity, and a commitment to human rights, an end to AIDS is within reach.